In recent years, in the field of medical health, with the continuous deepening of medical reform, the continuous entry of industries and capital, the continuous development and improvement of emerging technologies, and the development of micro-invasive surgery have also been put on the agenda. According to WinterGreen Research, the global surgical robot market will reach 20 billion US dollars in 2021, with a compound growth rate of about 30%. At this stage, for the surgical robot market, the largest market in the world is the North American market. As the medical investment of the domestic government is increasing, the medical system is beginning to reorganize, and the awareness of minimally invasive surgery for domestic patients is gradually increasing. The market focus in the future will gradually increase. Transfer to the Asian market. Billion Europe Health April 9 news, Bohns today announced the completion of 100 million A round of financing, this round of financing led by Deyi Capital, Ruihua Holdings and Tianzhu Investment joint investment. The funds raised in this round will be used to support the company to complete the registration certification of the full range of minimally invasive surgery robots and the pre-market preparation work. Founded in 2016, Boons is focused on the development, manufacturing and clinical application of precision surgical robots, focusing on artificial intelligence medicine. Headquartered in Tianfu Software Park and Bio City, Chengdu High-tech Zone, the R&D Center is located in Silicon Valley, USA. At the same time, Bohns was founded by Dr. Li Yao, a scientist at the Stanford Artificial Intelligence Laboratory Robot Center, and Dr. William Levine, an IEEE Lifelong Fellow. The Born's series of porous laparoscopic minimally invasive robots are mainly aimed at the clinical needs of minimally invasive surgery, focusing on breakthrough core technology of human-computer interaction control, realizing the organic integration of robotic surgery and traditional minimally invasive surgical equipment. Intelligent, precise and remote upgrades. It is reported that Boons has many innovations and breakthroughs in advanced surgical robots and intelligent surgery. In 2017, it won the only annual Innovation Product Award and the Annual Innovation Enterprise Award from Tianfu Software Park. According to BCG Boston Consulting Forecast, the global medical robot industry will stabilize at a compound annual growth rate of 15.4% in the next five years. By 2020, the global medical robot scale is expected to reach US$11.4 billion. At present, more than 600,000 robotic operations have been successfully carried out in more than 800 hospitals in 33 countries around the world. The types of surgery cover the departments of gastrointestinal surgery, hepatobiliary surgery and urology. Male Sexual Enhancement Ingredients Plant Extract Male Sexual Enhancement Ingredients Plant Extract,Epimedium Extract,Schisandra Chinensis Extract,Cistanche Tubulosa Extract Fufeng Sinuote Biotechnology Co.,Ltd. , https://www.sinuotebio.com